Skip to content

Effects of Synchronised Auditory Stimulations of the Sleep Slow Oscillation on Deep Sleep Quality

Effects of Synchronised Auditory Stimulations of the Sleep Slow Oscillation on Deep Sleep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02956161
Acronym
STIMENPHASE
Enrollment
24
Registered
2016-11-07
Start date
2016-09-30
Completion date
2016-11-30
Last updated
2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Sleep, Auditory stimulations, Slow oscillations

Brief summary

This monocentric, cross-over, randomised, double blind and placebo-controlled study evaluates the effects of auditory stimulations of the sleep slow oscillation on deep sleep quality.

Detailed description

Sleep quality impairment has long been identified as a risk factor to develop cardio-vascular, metabolic and more recently neurodegenerative diseases. The slow wave sleep, characterized by slow oscillations, has a major role on memory and hormones releasing. Here, we aim to assess a miniaturized sleep device that would automatically detect and stimulate sleep slow oscillations with sounds to enhance deep sleep quality. The subjects realize 3 conditions : * Up condition : Auditory stimulations are delivered in synchrony with the up phase of slow oscillations during N3 sleep stage. * Random condition : Auditory stimulations are randomly delivered during N3 sleep stage. * Placebo condition: The device is worn without any auditory stimulations delivered. The subjects are equipped with a reference polysomnography and the auditory stimulation device during 3 nights and one habituation night prior to them. A wash out period of 6 days between each night will be respected.

Interventions

DEVICEStimulation of up-phase of sleep slow oscillation
DEVICERandom stimulation of up phase of sleep slow oscillation

Sponsors

University of Paris 5 - Rene Descartes
CollaboratorOTHER
Dreem
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy subject * moderate morningness, intermediate or moderate eveningness chronotype (Horne & Östberg questionnaire)

Exclusion criteria

* sleep disorder according to the ICSD-3 or DSM-5 * travelling away from more than a time zone in the previous month * acute or chronic disorders (cardio-vascular, respiratory, neurologic, psychiatric) * night shifts work * smoking more than 5 cigarettes per day * drinking more than 5 glass of alcohol per week * consuming excessive drinks with xanthics (coffee, tea, coke more than 6 cups per day). * having a body mass index \>30kg.m -2 * being pregnant

Design outcomes

Primary

MeasureTime frameDescription
Variation of the amplitude of sleep slow oscillations3 daysAmplitude of sleep slow oscillation assessed during N3 sleep stages throughout 3 separate nights. The analysis is based on electroencephalography signal.

Secondary

MeasureTime frameDescription
Variation of the number of sleep slow oscillations3 daysNumber of sleep slow oscillation assessed during N3 sleep stages throughout 3 separate nights. The analysis is based on electroencephalography signal.
Variation of N3 sleep stage duration3 daysN3 sleep duration assessed throughout 3 separate nights. The analysis is based on double scoring of polysomnography signal.
Variation of the number of remembered words in declarative memory tasks (word pair task)3 daysNumber of remembered words assessed 3 separate days (30 min after awakening).
Variation of mood assessment measured with the profile of mood scale (POMS)3 daysMood assessed 3 separate days (30 min after awakening).
Variation of subjective sleepiness measured with the Karolinska sleepiness scale (KSS)3 daysSubjective sleepiness assessed 3 separate days (30 min after awakening).
Variation of average response time variation and omissions in the Psychomotor vigilance task (PVT)3 daysPsychomotor vigilance assessed 3 separate days (30 min after awakening).
Variation of salivary cortisol concentration3 daysSalivary cortisol concentration assessed 3 separate days (5 min after awakening).
Variation of salivary testosterone concentration3 daysSalivary testosterone concentration assessed 3 separate days (5 min after awakening).
Variation of mental rotation capacity (mental rotatory task)3 daysMental rotation capacity assessed 3 separate days (30 min after awakening).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026